within Pharmacolibrary.Drugs.ATC.S;

model S01AX01
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 8.333333333333333e-07,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01AX01</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Mercury compounds refer to chemical substances containing mercury, historically used as antiseptics (e.g., mercuric chloride, thiomersal), ophthalmic agents, and in other medicinal preparations. Due to their toxicity and risk of mercury poisoning, their therapeutic use has been largely discontinued and they are not approved for medical use today in most countries.</p><h4>Pharmacokinetics</h4><p>No specific human pharmacokinetic studies for mercury compounds (as S01AX01, for ophthalmic use) in contemporary scientific literature. Estimated parameters based on known pharmacokinetics of inorganic mercury compounds from historical toxicological data; parameters may vary considerably by specific compound and route.</p><h4>References</h4><ol><li><p>Kern, JK, et al., &amp; Geier, MR (2020). Examining the evidence that ethylmercury crosses the blood-brain barrier. <i>Environmental toxicology and pharmacology</i> 74 103312–None. DOI:<a href=\"https://doi.org/10.1016/j.etap.2019.103312\">10.1016/j.etap.2019.103312</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31841767/\">https://pubmed.ncbi.nlm.nih.gov/31841767</a></p></li><li><p>Chan, TY (2011). Inorganic mercury poisoning associated with skin-lightening cosmetic products. <i>Clinical toxicology (Philadelphia, Pa.)</i> 49(10) 886–891. DOI:<a href=\"https://doi.org/10.3109/15563650.2011.626425\">10.3109/15563650.2011.626425</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22070559/\">https://pubmed.ncbi.nlm.nih.gov/22070559</a></p></li><li><p>Geier, DA, et al., &amp; Geier, MR (2007). A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness. <i>Journal of toxicology and environmental health. Part B, Critical reviews</i> 10(8) 575–596. DOI:<a href=\"https://doi.org/10.1080/10937400701389875\">10.1080/10937400701389875</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18049924/\">https://pubmed.ncbi.nlm.nih.gov/18049924</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01AX01;
